Defensins neutralize anthrax toxin

This release is also available in German

The anthrax attacks in the aftermath of September 11, 2001 in the USA have illustrated the high potential of anthrax for misuse in bio-terrorism. Dissemination of anthrax by letters led to the death of 5 people and chemotherapeutic treatment of 30,000 individuals.

Now the team of Stefan H.E. Kaufmann, his PhD student Chun Kim and co-workers have developed a new therapeutic strategy against anthrax. In preclinical studies, these scientists showed that defensins neutralize the lethal toxin of anthrax bacilli and thus can prevent its deadly effect. Whilst defensins are well known to kill bacteria, toxin neutralization represents a novel function of defensins.

Defensins are capable of perforating the bacterial cell wall thus killing bacterial pathogens. Accordingly, their antibiotic potential is currently exploited although it is not clear when new chemotherapeutic agents on the basis of defensins will be available. The researchers, however, hope that a drug against anthrax toxin can be ready for human use within the next years.

Anthrax causes an infectious disease mostly in pigs, cattle, horses, sheep and goats. The disease is rare in humans and occurs primarily in regions with intensive farming. The lethal toxin (LeTx) composed of the lethal factor (LF) and the protective antigen (PA) is mostly responsible for the high mortality of anthrax. Although Bacillus anthracis can be treated by antibiotics, this chemotherapy frequently fails, in particular if not initiated immediately after infection, because even after eradication of the pathogen, bacterial toxins can remain in the circulation. "For this reason, new intervention strategies are urgently needed", says Stefan H.E. Kaufmann.


Contact: Prof. Stefan H.E. Kaufmann

Page: 1

Related biology news :

1. Defensins ward off HIV in two ways
2. Bleach found to neutralize mold allergens
3. Food preservative neutralizes anthrax spores
4. Antibody that neutralizes most HIV strains described by scientists at The Scripps Research Institute
5. A treatment, not a cure: Calcium silicate neutralizes an acidic stream
6. Taming the anthrax threat
7. New finding points way to foiling anthraxs tricks
8. UGA researchers discover cell-wall carbohydrate that is crucial to anthrax bacterium
9. New anthrax inhibitor could combat antibiotic-resistant strains
10. Combating anthrax: Results of study published this month as researchers look for a better vaccine
11. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax

Post Your Comments:

(Date:3/3/2020)... HILLS, Calif. (PRWEB) , ... March 03, 2020 , ... ... spinal levels with the dualX Expanding Interbody Fusion System. , The landmark ... Fresno, CA. After the case Dr. Najafi noted, “dualX has completely changed the ...
(Date:3/2/2020)... ... March 02, 2020 , ... ... Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy ( Pittcon 2020 ), being ... the world’s leading annual conference and exposition on laboratory science, attracting attendees from ...
(Date:2/28/2020)... ... February 27, 2020 , ... ... has formed Filtravate, its newest portfolio company. Established to develop and commercialize ... exclusively licensed from New Mexico State University (NMSU). The patent-pending technology results ...
Breaking Biology News(10 mins):
(Date:3/10/2020)... ... ... Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to ... suite of extended antigen in a gel testing format used for blood phenotyping for ... VISION® Max in the United States and Canada. The clearances allow testing for more ...
(Date:3/4/2020)... England (PRWEB) , ... March ... ... Ltd. , an industry-leading provider of recombinant antibody products and services, today ... offers customers the flexibility to rapidly express a large number of antibodies ...
(Date:3/3/2020)... DALLAS (PRWEB) , ... March 03, 2020 , ... ... MD, was invited to present the latest breast implant technology at the IMCAS ... start-ups and new innovations in the dermatology, plastic surgery, and aesthetic science industries ...
(Date:2/26/2020)... WILMINGTON, Del. (PRWEB) , ... February 25, 2020 ... ... (HMOs), DuPont Nutrition & Biosciences (DuPont) recently published the results of its safety ... of over 130 HMOs currently identified in human milk. These complex carbohydrates are ...
Breaking Biology Technology:
Cached News: